Thiverval Grignon, France

Pascal Bonnarme

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2015

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Pascal Bonnarme

Introduction

Pascal Bonnarme is a notable inventor based in Thiverval Grignon, France. He has made significant contributions to the field of cancer treatment through his innovative research and development. His work focuses on pharmaceutical compositions and methods that aim to combat cancer effectively.

Latest Patents

Pascal Bonnarme holds 1 patent related to his groundbreaking work. The patent pertains to methods and pharmaceutical compositions for treating cancer. More specifically, it involves a polypeptide that exhibits methionine gamma-lyase and homocysteinase activities. This invention highlights the potential use of such a polypeptide in cancer treatment, showcasing Bonnarme's commitment to advancing medical science.

Career Highlights

Throughout his career, Pascal Bonnarme has been associated with prestigious institutions. He has worked at the Institut National de la Santé et de la Recherche Médicale and the Institut National de la Recherche Agronomique. These experiences have allowed him to collaborate with leading experts in the field and contribute to significant advancements in medical research.

Collaborations

Pascal Bonnarme has collaborated with various professionals, including his coworker David Machover. Their joint efforts have furthered research initiatives and fostered innovation in cancer treatment methodologies.

Conclusion

Pascal Bonnarme's contributions to cancer research through his innovative patent and collaborations with esteemed institutions underscore his role as a significant figure in the field. His work continues to inspire advancements in pharmaceutical sciences and cancer treatment strategies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…